About Auralis Biotech
About Auralis Biotech: Science-Driven Commercial Consulting for Biotech
Auralis takes its name from the aurora - light that appears in the darkest skies. We believe in the power of possibility, in purpose-driven science, and in the people who dedicate their careers to advancing it. We help scientists, founders and companies across biotech, diagnostics, biopharma and life sciences create clarity, connection and forward momentum. Science should be a force for progress and impact, everywhere it is needed.
What is Auralis Biotech
Auralis Biotech is a European biotech consultancy founded in May 2025 and headquartered in Civitanova Marche, Italy. It is led by Giuseppina Sannino, a molecular biologist with a PhD in Cancer Biology and more than ten years of commercial experience in diagnostics, biopharma and molecular tools.
Legal entity: Auralis Biotech SRL, Via Zavatti 8, 62012 Civitanova Marche, Italy. VAT number IT10808851215.
We offer four services: biotech consulting (strategy, go-to-market and EU market entry), scientific websites and content, expert calls on immunodiagnostics and molecular diagnostics for investors and companies, and career coaching and training for scientists and company teams. We work with startups, established life science companies and investors in Europe, the US, the Middle East and Asia, across diagnostics, agrifood, environment, drug discovery and the wider life sciences.
Giuseppina Sannino, PhD
CEO and Founder
Dr. Sannino holds a PhD in Cancer Biology from the University of Tübingen and brings over 10 years of international experience in diagnostics, biopharma and molecular tools commercialization, across Europe, Africa, North America and China. She has led teams of sales, business development and application scientists.
She founded Auralis Biotech in May 2025 to unite scientific rigor with commercial purpose, translating complexity into clarity and laboratory validation into market momentum.
She is a startup mentor at AC75 Startup Accelerator and at Nucleate, where she gives hands-on guidance to early-stage teams in the Global Virtual Activator Program. She is also a reviewer for the BioExpert Network, evaluating R&D proposals and pitch decks from biotech start-ups.
Scientific Background
Dr. Sannino's academic research focused on molecular biology and cancer biology at the University of Tübingen. Her work contributed to the understanding of tumour microenvironment and cell signalling pathways.
How We Deliver
Auralis operates as an embedded extension of your team. For each engagement, we assemble a focused project team from our network of senior independent experts:
- Business development and commercial strategy
- Scientific marketing and content
- EU market access
Clients gain senior expertise without full-time overhead, with the flexibility to scale support as priorities shift.
Founder Perspective
Read Dr. Sannino's full CEO Weekly interview on building a science-driven biotech consulting venture.